The European Medical Journal's Latest Flagship Publication Is Here
Detailing a myriad of fascinating topics inside, the multidisciplinary publication of EMJ 3.3 is now available.
The Editor's Pick for this eJournal comes from Paubelle et al. on the use of chimeric antigen receptor (CAR) T cell therapy in acute myeloid leukaemia, offering a clear, understandable, direct, and comprehensive overview of the CAR T therapy story, while highlighting the difficulties encountered by researchers along the way.
As stated by Dr Emanuele Angelucci, an esteemed EMJ 3.3 (https://www.emjreviews.com/
Notes to Editors
If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email stacey.rivers@
Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.
Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you're interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/